Latest News for OPTI.CN
/PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of
/PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development PR Newswire VANCOUVER, BC,
/PRNewswire/ - via IBN - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for OPTI.CN.
Senate Trading
No Senate trades found for OPTI.CN.
U.S. House Trading
No House trades found for OPTI.CN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.